Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Fermion's TYK2 JH2 Inhibitor FZ007-119 Receives IND Approval from China's NMPA
Monday, February 05, 2024Fermion a clinicalstage pharmaceutical company focused on autoimmune diseases and pain management is delighted to announce the approval of its Investigational New Drug application for FZ by the China National Medical Products Administration
Junshi Biosciences Has Revealed That the Singapore Health Sciences Authority Has Accepted the New Drug Application for Toripalimab
Saturday, February 03, 2024Shanghai Junshi Biosciences Co Ltd has disclosed that the Singapore Health Sciences Authority accepted the New Drug Application for toripalimab This application includes the use of toripalimab in combination with cisplatin
Pixelgen Technologies Secures Distribution Agreement in the Japanese Market
Friday, February 02, 2024Pixelgen Technologies has recently announced a nonexclusive agreement with BioStream Co Ltd in Japan for the distribution of its spatial proteomics tools designed for single cells The collaboration aims to meet the increasing demand for Pixelgens fir...
Clearmind Medicine Secures Exclusive Long-Term Licensing Agreement with Leading Israeli Research Center
Friday, February 02, 2024Clearmind Medicine Inc a biotech company specializing in the discovery and development of novel psychedelicderived therapeutics for undertreated health issues has recently inked an exclusive longterm license agreement
Takeda and Protagonist Therapeutics Announce Global License and Collaboration Agreement for Rusfertide, an Advanced Rare Hematology Asset
Thursday, February 01, 2024Takeda and Protagonist Therapeutics Inc have inked a global license and collaboration agreement for the development and commercialization of rusfertide an investigational injectable hepcidin mimetic peptide
Infinity Bio Introduces Cutting-edge Antibody Profiling Platform Incorporating MIPSA Technology
Thursday, February 01, 2024Infinity Bio Inc proudly introduces its innovative antibody profiling platform driven by the stateoftheart Molecular Indexing of Proteins by SelfAssembly technology This groundbreaking platform represents a significant advancement in immune system
Bristol Myers Squibb's Breyanzi Receives Regulatory Approval in the U.S. and Japan for Relapsed or Refractory Follicular Lymphoma and Relapsed or Refractory Mantle Cell Lymphoma
Wednesday, January 31, 2024Bristol Myers Squibb has recently gained regulatory approval from both the US Food and Drug Administration and Japans Ministry of Health Labour and Welfare for its CAR T cell therapy known as Breyanzi
Regeneron Establishes Regeneron Cell Medicines Through the Acquisition of 2seventy Bio Platforms and Clinical Programs
Wednesday, January 31, 2024Regeneron Pharmaceuticals Inc has recently revealed the establishment of Regeneron Cell Medicines through a partnership with seventy bio Inc This collaboration grants Regeneron complete development and commercialization rights
Gracell Biotechnologies Receives FDA Clearance for Phase 1 Clinical Trial of FasTCAR-T GC012F as an Early-Line Therapy for Multiple Myeloma
Tuesday, January 30, 2024Gracell Biotechnologies Inc a global biopharmaceutical company specializing in the development of advanced cell therapies for cancer and autoimmune diseases has received approval from the US Food and Drug Administration
ENHERTU® Receives Priority Review in the U.S. for Patients Diagnosed with Metastatic HER2 Positive Solid Tumors
Monday, January 29, 2024Daiichi Sankyo and AstraZeneca have received acceptance and Priority Review from the US Food and Drug Administration for the supplemental Biologics License Application
